FOXL2 mutations and genomic rearrangements in BPES

Human Mutation

Volumn 30, Issue 2, 2009, Pages 158-169

  Beysen, Diane ^a   De Paepe, Anne ^a   De Baere, Elfride ^a  

^a GHENT UNIVERSITY HOSPITAL   (Belgium)

Author keywords

BPES; FOXL2; Genomic rearrangements; Genotype phenotype correlations

Indexed keywords

FORKHEAD TRANSCRIPTION FACTOR; TRANSCRIPTION FACTOR FOXL2; UNCLASSIFIED DRUG;

BLEPHAROPHIMOSIS; DNA POLYMORPHISM; FRAMESHIFT MUTATION; GENE DELETION; GENE DUPLICATION; GENE MUTATION; GENE REARRANGEMENT; GENE SEQUENCE; GENETIC COUNSELING; GENOTYPE PHENOTYPE CORRELATION; HUMAN; MISSENSE MUTATION; MOSAICISM; NONHUMAN; NONSENSE MUTATION; PREMATURE OVARIAN FAILURE; PRIORITY JOURNAL; REVIEW;

ANIMALS; BLEPHAROPHIMOSIS; FEMALE; FORKHEAD TRANSCRIPTION FACTORS; GENE REARRANGEMENT; GENOME, HUMAN; HUMANS; MUTATION; OVARIAN FAILURE, PREMATURE;

EID: 59749101082     PISSN: 10597794     EISSN: None     Source Type: Journal    
DOI: 10.1002/humu.20807     Document Type: Review

References (92)

1. Adell T, Muller WE. 2004. Isolation and characterization of five Fox (Forkhead) genes from the sponge Suberites domuncula. Gene 334:35-46.
2. Albrecht A, Mundlos S. 2005. The other trinucleotide repeat: polyalanine expansion disorders. Curr Opin Genet Dev 15:285-293.
3. Amiel J, Trochet D, Clement-Ziza M, Munnich A, Lyonnet S. 2004. Polyalanine expansions in human. Hum Mol Genet 13(Spec No 2):R235-R243.
4. Anasti JN. 1998. Premature ovarian failure: an update. Fertil Steril 70:1-15.
5. Baron D, Cocquet J, Xia X, Fellous M, Guiguen Y, Veitia RA. 2004. An evolutionary and functional analysis of FoxL2 in rainbow trout gonad differentiation. J Mol Endocrinol 33:705-715.
6. Baron D, Houlgatte R, Fostier A, Guiguen Y. 2005. Large-scale temporal gene expression profiling during gonadal differentiation and early gametogenesis in rainbow trout. Biol Reprod 73:959-966.
7. Batista F, Vaiman D, Dausset J, Fellous M, Veitia R. 2007. Potential targets of FOXL2, a transcription factor involved in craniofacial and follicular development, identified by transcriptomics. Proc Natl Acad Sci USA 104:3330-3335.
8. Baumstark A, Hameister H, Hakhverdyan M, Bakloushinskaya I, Just W. 2005. Characterization of Pisrt1/Foxl2 in Ellobius lutescens and exclusion as sex-determining genes. Mamm Genome 16:281-289.
9. Beckingsale PS, Sullivan TJ, Wong VA, Oley C. 2003. Blepharophimosis: a recommendation for early surgery in patients with severe ptosis. Clin Experiment Ophthalmol 31:138-142.
10. Bedaiwy MA, Falcone T. 2004. Ovarian tissue banking for cancer patients: reduction of post-transplantation ischaemic injury: intact ovary freezing and transplantation. Hum Reprod 19:1242-1244.
11. Bell R, Murday VA, Patton MA, Jeffery S. 2001. Two families with blepharophimosis/ptosis/epicanthus inversus syndrome have mutations in the putative forkhead transcription factor FOXL2. Genet Test 5:335-338.
12. Berry FB, Tamimi Y, Carle MV, Lehmann OJ, Walter MA. 2005. The establishment of a predictive mutational model of the forkhead domain through the analyses of FOXC2 missense mutations identified in patients with hereditary lymphedema with distichiasis. Hum Mol Genet 14:2619-2627.
13. Beysen D, Vandesompele J, Messiaen L, De Paepe A, De Baere E. 2004. The human FOXL2 mutation database. Hum Mutat 24:189-193.
14. Beysen D, Raes J, Leroy BP, Lucassen A, Yates JR, Clayton-Smith J, Ilyina H, Brooks SS, Christin-Maitre S, Fellous M, Fryns JP, Kim JR, Lapunzina P, Lemyre E, Meire F, Messiaen LM, Oley C, Splitt M, Thomson J, Van de Peer Y, Veitia RA, De Paepe A, De Baere E. 2005. Deletions involving long-range conserved nongenic sequences upstream and downstream of FOXL2 as a novel disease-causing mechanism in blepharophimosis syndrome. Am J Hum Genet 77:205-218.
15. Beysen D, De Jaegere S, Amor D, Bouchard P, Christin-Maitre S, Fellous M, Touraine P, Grix AW, Hennekam R, Meire F, Oyen N, Wilson LC, Barel D, Clayton-Smith J, de Ravel T, Decock C, Delbeke P, Ensenauer R, Ebinger F, Gillessen-Kaesbach G, Hendriks Y, Kimonis V, Laframboise R, Laissue P, Leppig K, Leroy BP, Miller DT, Mowat D, Neumann L, Plomp A, Van Regemorter N, Wieczorek D, Veitia RA, De Paepe A, De Baere E. 2008a. Identification of 34 novel and 56 known FOXL2 mutations in patients with Blepharophimosis syndrome. Hum Mutat 29:E205-219.
16. Beysen D, Moumné L, Veitia RA, Peters H, Leroy BP, De Paepe A, De Baere E. 2008b. Missense mutations in the forkhead domain of FOXL2 lead to subcellular mislocalisation, protein aggregation and impaired transactivation. Hum Mol Genet PMID: 18372316; online publication ahead of print.
17. Boccone L, Meloni A, Falchi AM, Usai V, Cao A. 1994. Blepharophimosis, ptosis, epicanthus inversus syndrome, a new case associated with de novo balanced autosomal translocation [46,XY,t(3;7)(q23;q32)]. Am J Med Genet 51:258-259.
18. Bodega B, Porta C, Crosignani PG, Ginelli E, Marozzi A. 2004. Mutations in the coding region of the FOXL2 gene are not a major cause of idiopathic premature ovarian failure. Mol Hum Reprod 10:555-557.
19. Brown LY, Brown SA. 2004. Alanine tracts: the expanding story of human illness and trinucleotide repeats. Trends Genet 20:51-58.
20. Caburet S, Demarez A, Moumné L, Fellous M, De Baere E, Veitia RA. 2004. A recurrent polyalanine expansion in the transcription factor FOXL2 induces extensive nuclear and cytoplasmic protein aggregation. J Med Genet 41:932-936.
21. Carlsson P, Mahlapuu M. 2002. Forkhead transcription factors: key players in development and metabolism. Dev Biol 250:1-23.
22. Cha SC, Jang YS, Lee JH, Kim HK, Kim SC, Kim S, Baek SH, Jung WS, Kim JR. 2003. Mutational analysis of forkhead transcriptional factor 2 (FOXL2) in Korean patients with blepharophimosis-ptosis-epicanthus inversus syndrome. Clin Genet 64:485-490.
23. Chian RC, Lim JH, Tan SL. 2004. State of the art in in-vitro oocyte maturation. Curr Opin Obstet Gynecol 16:211-219.
24. Cocquet J, Pailhoux E, Jaubert F, Servel N, Xia X, Pannetier M, De Baere E, Messiaen L, Cotinot C, Fellous M, Veitia RA. 2002. Evolution and expression of FOXL2 J Med Genet 39:916-921.
25. Cocquet J, De Baere E, Gareil M, Pannetier M, Xia X, Fellous M, Veitia RA. 2003. Structure, evolution and expression of the FOXL2 transcription unit. Cytogenet Genome Res 101:206-211.
26. Crisponi L, Deiana M, Loi A, Chiappe F, Uda M, Amati P, Bisceglia L, Zelante L, Nagaraja R, Porcu S, Ristaldi MS, Marzella R, Rocchi M, Nicolino M, Lienhardt-Roussie A, Nivelon A, Verloes A, Schlessinger D, Gasparini P, Bonneau D, Cao A, Pilia G. 2001. The putative forkhead transcription factor FOXL2 is mutated in blepharophimosis/ptosis/epicanthus inversus syndrome. Nat Genet 27:159-166.
27. Crisponi L, Uda M, Chiappe F, Deiana M, Usala GL, Marongiu M, Amati P, Bonneau D, Faravelli F, Tolmie J, Bisceglia L, Piemontese MR, Zelante L, Gasparini P, Crisponi G, Boccone L, Iolascon A, Percesepe A, Forabosco A, Pilia G, and FOXL2 Study Group. 2002. Genetic basis for non-syndromic and syndromic, blepharophimosis/ptosis and epicanthus inversus syndrome (BPES)-associated premature ovarian failure (POF). Am J Hum Genet 71(Suppl):324.
28. Crisponi L, Uda M, Deiana M, Loi A, Nagaraja R, Chiappe F, Schlessinger D, Cao A, Pilia G. 2004. FOXL2 inactivation by a translocation 171 kb away: analysis of 500 kb of chromosome 3 for candidate long-range regulatory sequences. Genomics 83:757-764.
29. De Baere E, Fukushima Y, Small K, Udar N, Van Camp G, Verhoeven K, Palotie A, De Paepe A, Messiaen L. 2000. Identification of BPESC1, a novel gene disrupted by a balanced chromosomal translocation, t(3;4)(q23;p15.2), in a patient with BPES. Genomics 68:296-304.
30. De Baere E, Dixon MJ, Small KW, Jabs EW, Leroy BP, Devriendt K, Gillerot Y, Mortier G, Meire F, Van Maldergem L, Courtens W, Hjalgrim H, Huang S, Liebaers I, Van Regemorter N, Touraine P, Praphanphoj V, Verloes A, Udar N, Yellore V, Chalukya M, Yelchits S, De Paepe A, Kuttenn F, Fellous M, Veitia R, Messiaen L. 2001. Spectrum of FOXL2 gene mutations in blepharophimosis-ptosis- epicanthus inversus (BPES) families demonstrates a genotype-phenotype correlation. Hum Mol Genet 10:1591-1600.
31. De Baere E, Lemercier B, Christin-Maitre S, Durval D, Messiaen L, Fellous M, Veitia R. 2002. FOXL2 mutation screening in a large panel of POF patients and XX males. J Med Genet 39:e43.
32. De Baere E, Beysen D, Oley C, Lorenz B, Cocquet J, De Sutter P, Devriendt K, Dixon M, Fellous M, Fryns JP, Garza A, Jonsrud C, Koivisto PA, Krause A, Leroy BP, Meire F, Plomp A, Van Maldergem L, De Paepe A, Veitia R, Messiaen L. 2003. FOXL2 and BPES: mutational hotspots, phenotypic variability, and revision of the genotype-phenotype correlation. Am J Hum Genet 72:478-487.
33. de Ru MH, Gille JJ, Nieuwint AW, Bijlsma JB, van der Blij JF, van Hagen JM. 2005. Interstitial deletion in 3q in a patient with blepharophimosis-ptosis- epicanthus inversus syndrome (BPES) and microcephaly, mild mental retardation an growth delay: clinical report and review of the literature. Am J Med Genet 15:81-87.
34. Dermitzakis ET, Reymond A, Scamuffa N, Ucla C, Kirkness E, Rossier C, Antonarakis SE. 2003. Evolutionary discrimination of mammalian conserved non-genic sequences (CNGs). Science 302:1033-1035.
35. Dollfus H, Stoetzel C, Riehm S, Lahlou Boukoffa W, Bediard Boulaneb F, Quillet R, Abu-Eid M, Speeg-Schatz C, Francfort JJ, Flament J, Veillon F, Perrin-Schmitt F. 2003. Sporadic and familial blepharophimosis-ptosis-epicanthus inversus syndrome: FOXL2 mutation screen and MRI study of the superior levator eyelid muscle. Clin Genet 63:117-120.
36. Donnez J, Martinez-Madrid B, Jadoul P, Van Langendonckt A, Demylle D, Dolmans MM. 2006. Ovarian tissue cryopreservation and transplantation: a review. Hum Reprod Update 12:519-535.
37. Ellsworth BS, Egashira N, Haller JL, Butts DL, Cocquet J, Clay CM, Osamura RY, Camper SA. 2006. FOXL2 in the pituitary: molecular, genetic, and developmental analysis. Mol Endocrinol 20:2796-2805.
38. Fokkema IF, den Dunnen JT, Taschner PE. 2005. LOVD: easy creation of a locusspecific sequence variation database using an "LSDB-in-a-box" approach. Hum Mutat 26:63-68.
39. Fokstuen S, Antonarakis SE, Blouin JL. 2003. FOXL2-mutations in blepharophimosis-ptosis-epicanthus inversus syndrome (BPES): challenges for genetic counseling in female patients. Am J Med Genet 117A:143-146.
40. Fukushima Y,Wakui K, Nishida T, Ueoka Y. 1991. Blepharophimosis sequence and de novo balanced autosomal translocation [46,XY,t(3;4)(q23;p15.2)]: possible assignment of the trait to 3q23. Am J Med Genet 40:485-487.
41. Gersak K, Harris SE, Smale WJ, Shelling AN. 2004. A novel 30 bp deletion in the FOXL2 gene in a phenotypically normal woman with primary amenorrhoea: case report. Hum Reprod 19:2767-2770.
42. Goodman FR, Mundlos S, Muragaki Y, Donnai D, Giovannucci-Uzielli ML, Lapi E, Majewski F, McGaughran J, McKeown C, Reardon W, Upton J, Winter RM, Olsen BR, Scambler PJ. 1997. Synpolydactyly phenotypes correlate with size of expansions in HOXD13 polyalanine tract. Proc Natl Acad Sci USA 94:7458-7463.
43. Goswami D, Conway GS. 2005. Premature ovarian failure. Hum Reprod Update 11:391-410.
44. Govoroun MS, Pannetier M, Pailhoux E, Cocquet J, Brillard JP, Couty I, Batellier F, Cotinot C. 2004. Isolation of chicken homolog of the FOXL2 gene and comparison of its expression patterns with those of aromatase during ovarian development. Dev Dyn 231:859-870.
45. Grantham R. 1974. Amino acid difference formula to help explain protein evolution. Science 185:862-864.
46. Harris SE, Chand AL, Winship IM, Gersak K, Aittomaki K, Shelling AN. 2002. Identification of novel mutations in FOXL2 associated with premature ovarian failure. Mol Hum Reprod 8:729-733.
47. Horsnell K, Ali M, Malik S, Wilson L, Hall C, Debeer P, Crow Y. 2006. Clinical phenotype associated with homozygosity for a HOXD13 7-residue polyalanine tract expansion. Eur J Med Genet 49:396-401.
48. Kalantaridou SN, Davis SR, Nelson LM. 1998. Premature ovarian failure. Endocrinol Metab Clin North Am 27:989-1006.
49. Kleinjan DA, van Heyningen V. 2005. Long-range control of gene expression: emerging mechanisms and disruption in disease. Am J Hum Genet 76:8-32.
50. Kosaki K, Ogata T, Kosaki R, Sato S, Matsuo N. 2002. A novel mutation in the FOXL2 gene in a patient with blepharophimosis syndrome: differential role of the polyalanine tract in the development of the ovary and the eyelid. Ophthalmic Genet 23:43-47.
51. Kumar A, Babu M, Raghunath A, Venkatesh CP. 2004. Genetic analysis of a five generation Indian family with BPES: a novel missense mutation (p.Y215C). Mol Vis 10:445-449.
52. Lehmann OJ, Sowden JC, Carlsson P, Jordan T, Bhattacharya SS. 2003. Fox's in development and disease. Trends Genet 19:339-344.
53. Li WX, Wang XK, Sun Y, Wang YL, Lin LX, Tang SJ. 2005. A novel mutation in the FOXL2 gene in a Chinese family with blepharophimosis, ptosis, and epicanthus inversus syndrome. Zhonghua Yi Xue Yi Chuan Xue Za Zhi 22:372-375.
54. Loffler KA, Zarkower D, Koopman P. 2003. Etiology of ovarian failure in blepharophimosis ptosis epicanthus inversus syndrome: FOXL2 is a conserved, early-acting gene in vertebrate ovarian development. Endocrinology 144:3237-3243.
55. Lucena E, Bernal DP, Lucena C, Rojas A, Moran A, Lucena A. 2006. Successful ongoing pregnancies after vitrification of oocytes. Fertil Steril 85:108-111.
56. Moumné L, Fellous M, Veitia RA. 2005. Deletions in the polyAlanine-containing transcription factor FOXL2 lead to intranuclear aggregation. Hum Mol Genet 14:3557-6564.
57. Moumné L, Dipietromaria A, Batista F, Kocer A, Fellous M, Pailhoux E, Veitia RA. 2008. Differential aggregation and functional impairment induced by polyalanine expansions in FOXL2, a transcription factor involved in cranio-facial and ovarian development. Hum Mol Genet 17:1010-1019.
58. Nakamoto M, Matsuda M, Wang DS, Nagahama Y, Shibata N. 2006. Molecular cloning and analysis of gonadal expression of Foxl2 in the medaka, Oryzias latipes. Biochem Biophys Res Commun 344:353-361.
59. Nallathambi J, Moumné L, De Baere E, Beysen D, Usha K, Sundaresan P, Veitia RA. 2007. A novel polyalanine expansion in FOXL2: the first evidence for a recessive form of the blepharophimosis syndrome (BPES) associated with ovarian dysfunction. Hum Genet 121:107-112.
60. Nallathambi J, Laissue P, Batista F, Benayoun B, Lesaffre C, Moumné L, Pandaranayaka PJE, Usha K, Krishnaswamy S, Sundaresan P, Veitia RA. 2008. Differential functional effects of novel mutations of the transcription factor FOXL2 in BPES patients. Hum Mutat 29; online publication ahead of print.
61. Ng PC, Henikoff S. 2001. Predicting deleterious amino acid substitutions. Genome Res 11:863-874.
62. Nikic S, Vaiman D. 2004. Conserved patterns of gene expression in mice and goats in the vicinity of the Polled Intersex Syndrome (PIS) locus. Chromosome Res 12:465-474.
63. Or SF, Tong MF, Lo FM, Lam TS. 2006. Three novel FOXL2 gene mutations in Chinese patients with blepharophimosis-ptosis-epicanthus inversus syndrome. Chin Med J (Engl) 119:49-52.
64. Ottolenghi C, Omari S, Garcia-Ortiz JE, Uda M, Crisponi L, Forabosco A, Pilia G, Schlessinger D. 2005. Foxl2 is required for commitment to ovary differentiation. Hum Mol Genet 14:2053-2062.
65. Ottolenghi C, Pelosi E, Tran J, Colombino M, Douglass E, Nedorezov T, Cao A, Forabosco A, Schlessinger D. 2007. Loss of Wnt4 and Foxl2 leads to female-to-male sex reversal extending to germ cells. Hum Mol Genet 16:2795-2804.
66. Pailhoux E, Vigier B, Chaffaux S, Servel N, Taourit S, Furet JP, Fellous M, Grosclaude F, Cribiu EP, Cotinot C, Vaiman D. 2001. A 11.7-kb deletion triggers intersexuality and polledness in goats. Nat Genet 29:453-458.
67. Pannetier M, Renault L, Jolivet G, Cotinot C, Pailhoux E. 2005. Ovarian-specific expression of a new gene regulated by the goat PIS region and transcribed by a FOXL2 bidirectional promoter. Genomics 85:715-726.
68. Piemontese M, Gasparini P, Zelante L. 2002. Paternal constitutional mosaicism in familial BPES. Eur J Hum Genet 10:131.
69. Pisarska MD, Bae J, Klein C, Hsueh AJ. 2004. Forkhead L2 is expressed in the ovary and represses the promoter activity of the steroidogenic acute regulatory gene. Endocrinology 145:3424-3433.
70. Praphanphoj V, Goodman BK, Thomas GH, Niel KM, Toomes C, Dixon MJ, Geraghty MT. 2000. Molecular cytogenetic evaluation in a patient with a translocation (3;21) associated with blepharophimosis, ptosis, epicanthus inversus syndrome (BPES). Genomics 65:67-69.
71. Qian X, Shu A, Qin W, Xing Q, Gao J, Yang J, Feng G, He L. 2004. A novel insertion mutation in the FOXL2 gene is detected in a big Chinese family with blepharophimosis-ptosis-epicanthus inversus. Mutat Res 554:19-22.
72. Raile K, Stobbe H, Trobs RB, Kiess W, Pfaffle R. 2005. A new heterozygous mutation of the FOXL2 gene is associated with a large ovarian cyst and ovarian dysfunction in an adolescent girl with blepharophimosis/ptosis/epicanthus inversus syndrome. Eur J Endocrinol 153:353-358.
73. Ramensky V, Bork P, Sunyaev S. 2002. Human non-synonymous SNPs: server and survey. Nucleic Acids Res 30:3894-3900.
74. Ramírez-Castro JL, Pineda-Trujillo N, Valencia AV, Muñetón CM, Botero O, Trujillo O, Vásquez G, Mora BE, Durango N, Bedoya G, Ruiz-Linares A. 2002. Mutations in FOXL2 underlying BPES (types 1 and 2) in Colombian families. Am J Med Genet 113:47-51.
75. Schmidt D, Ovitt CE, Anlag K, Fehsenfeld S, Gredsted L, Treier AC, Treier M. 2004. The murine winged-helix transcription factor Foxl2 is required for granulosa cell differentiation and ovary maintenance. Development 131:933-942.
76. Tang S, Wang X, Lin L, Sun Y, Wang Y, Yu H. 2006. Mutation analysis of the FOXL2 gene in Chinese patients with blepharophimosis-ptosis-epicanthus inversus syndrome. Mutagenesis 21:35-39.
77. Treier M, Gleiberman AS, O'Connell SM, Szeto DP, McMahon JA, McMahon AP, Rosenfeld MG. 1998. Multistep signaling requirements for pituitary organogenesis in vivo. Genes Dev 12:1691-1704.
78. Tronina SA, Bobrova NF, Khrinenko VP. 2006. Clinical and anatomical substantiation of levator resection in the complex surgical treatment of BPES. Orbit 25:5-10.
79. Uda M, Ottolenghi C, Crisponi L, Garcia JE, Deiana M, Kimber W, Forabosco A, Cao A, Schlessinger D, Pilia G. 2004. Foxl2 disruption causes mouse ovarian failure by pervasive blockage of follicle development. Hum Mol Genet 13:1171-1181.
80. Udar N, Yellore V, Chalukya M, Yelchits S, Silva-Garcia R, Small K. 2003. Comparative analysis of the FOXL2 gene and characterization of mutations in BPES patients. Hum Mutat 22:222-228.
81. van Kasteren YM, Schoemaker J. 1999. Premature ovarian failure: a systematic review on therapeutic interventions to restore ovarian function and achieve pregnancy. Hum Reprod Update 5:483-492.
82. van Kasteren Y. 2001. Treatment concepts for premature ovarian failure. J Soc Gynecol Investig 8(Suppl Proceedings):S58-S59.
83. Varghese B, Donnai D, Shalet SM. 2002. Isolated growth hormone deficiency and BPES. Endocr Abstr 3:P13.
84. Vincent AL, Watkins WJ, Sloan BH, Shelling AN. 2005. Blepharophimosis and bilateral Duane syndrome associated with a FOXL2 mutation. Clin Genet 68:520-523.
85. Wales JKH. 1998. Hypergonadotropic hypogonadism in a 3-year-old girl with blepharophimosis, ptosis, and epicanthus inversus syndrome. Horm Res 50:341.
86. Wang D, Kobayashi T, Zhou L, Nagahama Y. 2004. Molecular cloning and gene expression of Foxl2 in the Nile tilapia, Oreochromis niloticus. Biochem Biophys Res Commun 320:83-89.
87. Wotton KR, French KE, Shimeld SM. 2007. The developmental expression of foxl2 in the dogfish Scyliorhinus canicula. Gene Expr Patterns 7:793-797.
88. Yamada T, Hayasaka S, Matsumoto M, Budu, Esa T, Hayasaka Y, Endo M. 2001. Heterozygous 17-bp deletion in the forkhead transcription factor gene, FOXL2, in a Japanese family with blepharophimosis-ptosis-epicanthus inversus syndrome. J Hum Genet 46:733-736.
89. Yamaguchi T, Yamaguchi S, Hirai T, Kitano T. 2007. Follicle-stimulating hormone signaling and Foxl2 are involved in transcriptional regulation of aromatase gene during gonadal sex differentiation in Japanese flounder, Paralichthys olivaceus. Biochem Biophys Res Commun 359:935-940.
90. Yoon TK, Kim TJ, Park SE, Hong SW, Ko JJ, Chung HM, Cha KY. 2003. Live births after vitrification of oocytes in a stimulated in vitro fertilization-embryo transfer program. Fertil Steril 79:1323-1326.
91. Zhao X, Sun M, Zhao J, Leyva JA, Zhu H, Yang W, Zeng X, Ao Y, Liu Q, Liu G, Lo WH, Jabs EW, Amzel LM, Shan X, Zhang X. 2007. Mutations in HOXD13 underlie syndactyly type V and a novel brachydactyly-syndactyly syndrome. Am J Hum Genet 80:361-371.
92. Zlotogora J, Sagi M, Cohen T. 1983. The blepharophimosis, ptosis, and epicanthus inversus syndrome: delineation of two types. Am J Hum Genet 35:1020-1027.